« Chew on this: the gum that fights cancer | Main | ASM: Moving target »

Cervical cancer vaccine comes closer to market

US committee recommends that FDA approve the jab for girls.

A vaccine against cervical cancer has made it one step closer to the doctor's office. On 18 May, an external advisory committee recommended to the US Food and Drug Administration (FDA) that they allow one such vaccine, called Gardasil, to be licensed for use in girls from the age of nine.

Read the story here.

Posted by Nicola Jones on May 22, 2006 05:56 PM |

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/616

Comments

Experts warned that the vaccine only offers protection for women who have not already been infected. It suggests Gardasil is likely to have the most benefit only when given to adolescents before their first sexual intercourse.

Posted by: Susan | June 14, 2006 11:56 AM

Post a comment

Comments will be reviewed by staff before being published. You can be as critical or controversial as you like, but please don't get personal or offensive, and do keep it brief. Excessively long entries may be cropped. Remember this is for feedback and discussion - not for publishing papers or press releases.

We strongly encourage you to use your real, full name. Email addresses are required: this is just in case we need to discuss your comment with you privately. They won’t be published.


Please enter the numbers you see below - this helps us to cut down on spam. Note that attempting to post within 30 seconds of hitting ‘preview’ or ‘post’ can cause the system to think you are spamming the site. If you are having trouble with this system, you can instead e-mail a comment to 'inthefield at nature.com'.

Search